To scale or not to scale: the principles of dose extrapolation

V Sharma, JH McNeill - British journal of pharmacology, 2009 - Wiley Online Library
The principles of inter‐species dose extrapolation are poorly understood and applied. We
provide an overview of the principles underlying dose scaling for size and dose adjustment …

Physiologically-based pharmacokinetics in drug development and regulatory science

M Rowland, C Peck, G Tucker - Annual review of pharmacology …, 2011 - annualreviews.org
The application of physiologically-based pharmacokinetic (PBPK) modeling is coming of
age in drug development and regulation, reflecting significant advances over the past 10 …

Personalized whole‐body models integrate metabolism, physiology, and the gut microbiome

I Thiele, S Sahoo, A Heinken, J Hertel… - Molecular systems …, 2020 - embopress.org
Comprehensive molecular‐level models of human metabolism have been generated on a
cellular level. However, models of whole‐body metabolism have not been established as …

[图书][B] Hayes' principles and methods of toxicology

AW Hayes, T Kobets - 2023 - taylorfrancis.com
Hayes' Principles and Methods of Toxicology has long been established as a reliable and
informative reference for the concepts, methodologies, and assessments integral to …

Design and demonstration of a pumpless 14 compartment microphysiological system

PG Miller, ML Shuler - Biotechnology and bioengineering, 2016 - Wiley Online Library
We describe a human “Body‐on‐a‐chip” device (or microphysiological system) that could be
used to emulate drug distribution, metabolism, and action in the body. It is based upon a …

Pumpless microfluidic platform for drug testing on human skin equivalents

HE Abaci, K Gledhill, Z Guo, AM Christiano, ML Shuler - Lab on a Chip, 2015 - pubs.rsc.org
Advances in bio-mimetic in vitro human skin models increase the efficiency of drug
screening studies. In this study, we designed and developed a microfluidic platform that …

Body-on-a-chip simulation with gastrointestinal tract and liver tissues suggests that ingested nanoparticles have the potential to cause liver injury

MB Esch, GJ Mahler, T Stokol, ML Shuler - Lab on a Chip, 2014 - pubs.rsc.org
The use of nanoparticles in medical applications is highly anticipated, and at the same time
little is known about how these nanoparticles affect human tissues. Here we have simulated …

In vivo methods for drug absorption–comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation/API …

E Sjögren, B Abrahamsson, P Augustijns… - European Journal of …, 2014 - Elsevier
This review summarizes the current knowledge on anatomy and physiology of the human
gastrointestinal tract in comparison with that of common laboratory animals (dog, pig, rat and …

Human-on-a-chip design strategies and principles for physiologically based pharmacokinetics/pharmacodynamics modeling

HE Abaci, ML Shuler - Integrative Biology, 2015 - academic.oup.com
Advances in maintaining multiple human tissues on microfluidic platforms has led to a
growing interest in the development of microphysiological systems for drug development …

Modular, pumpless body-on-a-chip platform for the co-culture of GI tract epithelium and 3D primary liver tissue

MB Esch, H Ueno, DR Applegate, ML Shuler - Lab on a Chip, 2016 - pubs.rsc.org
We have developed an expandable modular body-on-a-chip system that allows for a plug-
and-play approach with several in vitro tissues. The design consists of single-organ chips …